BioCryst
Medical AFFAIRS
Navigate the Biocryst Medical Affairs Hub with ease
Throughout this resource hub you will find up-to-date information on developing and approved BioCryst medicines, including clinical trials, congress information, published data, and other research material.
Search for medical information
Find information on BioCryst products.
Find information
on previous and upcoming congresses
Upcoming Congress Events
2025 AMCP Congress
BioCryst will attend the 2025 AMCP Congress from March 31 to April 3, 2025.
Visit the Congress Website for More Information
Materials From Recent Congresses
Showing 5 Materials
-
Exploring the Role of Disease Burden, Treatment Effectiveness, and Administration Preference on Willingness of Patients With HAE to Change Long-Term Prophylaxis
AAAAI | 2025 | Hereditary Angioedema (HAE) -
HAE attack rates in pediatric patients 2 to <12 years of age with prophylactic berotralstat: results from interim analysis of APeX-P
AAAAI | 2025 | Hereditary Angioedema (HAE) -
Real-world attack rates before and after berotralstat initiation among patients with hereditary angioedema with C1-inhibitor deficiency (type I/II) stratified by monthly baseline HAE attack frequency
AAAAI | 2025 | Hereditary Angioedema (HAE) -
Real-world attack rates before and after berotralstat initiation among patients with hereditary angioedema without C1-inhibitor deficiency (HAE-nl-C1-INH) stratified by monthly baseline HAE attack frequency
AAAAI | 2025 | Hereditary Angioedema (HAE) -
Patient-reported impact of berotralstat as long-term prophylaxis on hereditary angioedema attack frequency and attack severity
AAAAI | 2025 | Hereditary Angioedema (HAE)
Current clinical trials and research
Learn more about medicines being developed at BioCryst and see the latest studies.
Discover more about our areas of focus
Ready to connect or have a question?
Have questions about any of our medicines that are currently approved or in development, or would you like to request to be connected with an MSL?
Have questions about our company?